- \n
- Conditions les plus discut\u00e9es pendant la p\u00e9riode d'\u00e9coute<\/li>\n\n\n\n
- Messages ayant g\u00e9n\u00e9r\u00e9 le plus d'engagement<\/li>\n\n\n\n
- Essais cl\u00e9s mentionn\u00e9s<\/li>\n\n\n\n
- Une plong\u00e9e en profondeur dans les principaux d\u00e9veloppements pr\u00e9sent\u00e9s lors de la conf\u00e9rence<\/li>\n<\/ul>\n\n\n\n
Du point de vue des entreprises pharmaceutiques :<\/strong><\/p>\n\n\n\n
- \n
- Les principales entreprises pharmaceutiques (en termes d'engagement et de mentions) et l'impact de leur communication en ligne, y compris les mentions d\u00e9tenues et gagn\u00e9es.<\/li>\n\n\n\n
- Aper\u00e7u de ce qui a \u00e9t\u00e9 communiqu\u00e9 par les principales soci\u00e9t\u00e9s pharmaceutiques...<\/li>\n<\/ul>\n\n\n\n
Champ d'application<\/h2>\n\n\n\n
L'analyse porte sur les mentions provenant du monde entier*.<\/p>\n\n\n\n
Il y a eu un total de 11K mentions de HCP et 502 mentions autour des entreprises pharmaceutiques enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute du 2 d\u00e9cembre 2023 au 19 d\u00e9cembre 2023 (deux semaines avant et une semaine apr\u00e8s la conf\u00e9rence).<\/p>\n\n\n\n
Toutes les mentions proviennent de Twitter.<\/p>\n\n\n\n
Au total, 744 auteurs uniques ont \u00e9t\u00e9 identifi\u00e9s.<\/p>\n\n\n\n
*#ash23 OR #ash2023 OR #ASHTrainee OR #ASHkudos OR #ASHRunWalk OR #ASHaiku<\/p>\n\n\n\n
M\u00e9thodologie<\/h2>\n\n\n\n
![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/01\/image-png-jan-12-2024-10-50-11-8820-am.webp\")
<\/figure>\n\n\n\nVolume des conversations<\/h2>\n\n\n\n
Comme d'habitude, le pic des conversations a eu lieu pendant la conf\u00e9rence, repr\u00e9sentant 77% des mentions enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute.<\/p>\n\n\n\n
![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/01\/image-png-jan-12-2024-10-50-40-1834-am.webp\")
<\/figure>\n\n\n\nASH23 : Focus sur les professionnels de la sant\u00e9<\/h2>\n\n\n\n
![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/01\/image-png-jan-12-2024-10-52-37-3242-am.webp\")
<\/figure>\n\n\n\nHauts de page hashtags<\/h3>\n\n\n\n
\n\n![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/01\/image-png-jan-12-2024-10-53-45-5659-am.webp\")
<\/figure>\n<\/div>\n\n\n\n\n![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/01\/image-png-jan-12-2024-10-54-37-7396-am.webp\")
<\/figure>\n<\/div>\n<\/div>\n\n\n\nPart de voix (SOV) des pathologies les plus discut\u00e9es (# de mentions) : le my\u00e9lome multiple, la leuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb et le lymphome diffus \u00e0 grandes cellules B ont domin\u00e9 les discussions en ligne.<\/p>\n\n\n\n
![\"\"](\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/01\/image-png-jan-12-2024-10-56-09-0954-am.webp\")
<\/figure>","protected":false},"excerpt":{"rendered":"The 65th ASH annual meeting and exposition took place on December 09-12, 2023, in San Diego, California. The schedule at a glance is available here. This year\u2019s event was primarily an in-person event with virtual broadcasts available. Like last year, APLUSA exhibited in person with a physical booth. With this social media analysis, we will […]<\/p>\n","protected":false},"author":4,"featured_media":849,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"Explore the ASH 2023 social media impact: top HCP discussions, key trials, leading pharma engagement, and insights from 11K global mentions.","_seopress_robots_index":"","content-type":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-99","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-views"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/99","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/comments?post=99"}],"version-history":[{"count":0,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/99\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/849"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=99"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/categories?post=99"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/tags?post=99"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}